Antacids Market Size ,Share ,Industry Growth ,Key Players And Forecast To 2025| Grand View Research, Inc
“The global antacids market size was valued at USD 5.83 billion in 2017 and is projected to expand at a CAGR of 3.9% over the forecast period .”
The global antacid market size is expected to reach USD 7.91 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 3.9% over the forecast period. The trend of self-medication for occasional heartburn is one of the major factors driving the market. Growing geriatric population is expected to positively impact the overall market for antacid. According to the United Nations Department of Economic And Social Affairs (DESA), the global elderly population (60 years and above), was around 962 million in 2017. This number is expected to grow at the fastest rate in Latin America with 71% increase in population aged 60 and over, followed by Asia with 66%, Africa with 64%, North America with 41%, and Europe with 23%. Key players operating in antacid market focus on product enhancement to cater to patient requirements, such as changing the dosage form into chewable tablets, powder, and jelly. Also, these players are involved in collaborations and acquisitions to expand their market presence. For instance, in 2017, Pfizer, Inc. entered into a strategic agreement with AstraZeneca to acquire one of the antacid brands, Neksium for a value of INR 75 crores in India to boost its product portfolio. The easy availability of antacids over-the-counter offer growth opportunities for the sales of overall market. Some of the key players areGlaxoSmithKline plc; AstraZeneca; Pfizer, Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy’s Laboratories Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/antacids-market
Follow Us:
Further key findings from the report suggest: In 2017, tablet segment led the antacid market due to high efficacy compared to other dosage forms. Liquid is anticipated to be the fastest growing segment due to its palatable taste and preferred choice for children and elderly population
Retail pharmacy led the distribution channel segment due its accessibility and availability. Online pharmacy is anticipated to be the fastest growing segment due to growing adoption of Pharma 3.0 and consumer awareness
Asia Pacific is estimated to be the largest and fastest growing region over the forecast period due to presence of key players such as GlaxoSmithKline plc; Pfizer Inc.; and Abbott among others
North America held the second largest market share in 2017 owing to increasing prevalence of different digestive disorders
Some of the key companies operating in this market are GlaxoSmithKline plc; Bayer AG; Boehringer Ingelheim International GmbH; Dr. Reddy’s Laboratories Ltd.; Reckitt Benckiser Group plc; Sun Pharmaceuticals Ltd.; Sanofi; Takeda Pharmaceutical Company Limited; Pfizer Inc.; and Procter & Gamble.
Grand View Research has segmented the global antacid market based on dosage form, distribution channel, and region: Antacid Dosage Form Outlook (Revenue, USD Million, 2014 - 2025) Tablet
Liquid
Others
Antacid Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025) Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Antacid Regional Outlook (Revenue, USD Million, 2014 - 2025) North America
o
U.S.
o
Canada
Europe o
U.K.
o
Germany
Asia Pacific
Follow Us:
o
Japan
o
China
o
India
Latin America o
Brazil
o
Mexico
Middle East & Africa o
South Africa
Browse Related Category Reports @ www.grandviewresearch.com/industry/pharmaceuticals Table of Content of Antacids Market Chapter 1 Methodology And Scope 1.1 Research Methodology 1.2 Research Scope And Assumptions 1.3 List Of Tables Chapter 2 Executive Summary 2.1 Market Summary Chapter 3 Market Variables, Trends & Scope 3.1 Market Segmentation Chapter 4 Market Definitions Chapter 5 Industry Outlook 5.1 Market Variable Analysis 5.1.1 Increasing Prevelance Of Gastro Esophageal Reflux Diseases (GERD) 5.1.2 Growing Geriatric Population 5.1.3 Increasing Prevalence Of Heartburn 5.2 Market Restraint Analysis 5.2.1 Growing Number Of Alternatives In The Market For Antacids Chapter 6 Business Environment Analysis 6.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological) 6.2 Porter’s Five Forces Analysis Chapter 7 Dosage Form Business Analysis 7.1 Antacid Market: Dosage Form Movement Analysis 7.2 Tablet 7.2.1 Tablet Market Estimates And Forecast, 2014 - 2025
Follow Us:
7.3 Liquid 7.3.1 Liquid Market Estimates And Forecast, 2014 - 2025 7.4 Others 7.4.1 Others Market Estimates And Forecast, 2014 - 2025 Chapter 8 Distribution Channel Business Analysis 8.1 Antacid Market: Distribution Channel Movement Analysis 8.2 Retail Pharmacy 8.2.1 Retail Pharmacy Market Estimates And Forecast, 2014 - 2025 8.3 Hospital Pharmacy 8.3.1 Hospital Pharmacy Market Estimates And Forecast, 2014 - 2025 8.4 Online Pharmacy 8.4.1 Online Pharmcay Market Estimates And Forecast, 2014 - 2025 Chapter 9 Regional Business Analysis 9.1 Antacid Market: Regional Movement Analysis 9.2 North America 9.2.1 North America Market Estimates And Forecast, 2014 - 2025 9.2.2 U.S. 9.2.2.1 U.S. Market Estimates And Forecast, 2014 - 2025 9.2.3 Canada 9.2.3.1 Canada Market Estimates And Forecast, 2014 - 2025 9.3 Europe 9.3.1 Europe Market Estimates And Forecast, 2014 - 2025 9.3.2 Germany 9.3.3 Germany Market Estimates And Forecast, 2014 - 2025 9.3.4 U.K. 9.3.5 U.K. Market Estimates And Forecast, 2014 - 2025 9.4 Asia-Pacific 9.4.1 Asia-Pacific Market Estimates And Forecast, 2014 - 2025 9.4.2 Japan 9.4.2.1 Japan Market Estimates And Forecast, 2014 - 2025 9.4.3 China 9.4.3.1 China Market Estimates And Forecast, 2014 - 2025
Follow Us:
9.4.4 India 9.4.4.1 India Market Estimates And Forecast, 2014 - 2025 9.5 Latin America 9.5.1 Latin America Market Estimates And Forecast, 2014 - 2025 9.5.2 Brazil 9.5.2.1 Brazil Market Estimates And Forecast, 2014 - 2025 9.5.3 Mexico 9.5.3.1 Market Estimates And Forecast, 2014 - 2025 9.6 Middle East And Africa 9.6.1 Middle-East And Africa Market Estimates And Forecast, 2014 - 2025 9.6.2 South Africa 9.6.3 South Africa Market Estimates And Forecast, 2014 - 2025 Chapter 10 Company Profiles 10.1 Company Profiles 10.1.1 GlaxoSmithkline plc. 10.1.1.1 Company Overview 10.1.1.2 Financial Performance 10.1.1.3 Product Benchmarking 10.1.1.4 Strategic Initiatives 10.1.2 Bayer AG 10.1.2.1 Company Overview 10.1.2.2 Financial Performance 10.1.2.3 Product Benchmarking 10.1.2.4 Strategic Initiatives 10.1.3 Pfizer, Inc. 10.1.3.1 Company Overview 10.1.3.2 Financial Performance 10.1.3.3 Product Benchmarking 10.1.2.4 Strategic Initiatives 10.1.4 Boehringer Ingelheim International GmbH 10.1.4.1 Company Overview 10.1.4.2 Product Benchmarking
Follow Us:
10.1.4.3 Strategic Initiatives 10.1.5 Dr. Reddy’s Laboratories Ltd. 10.1.5.1 Company Overview 10.1.5.2 Financial Performance 10.1.5.3 Product Benchmarking 10.1.4.4 Strategic Initiatives 10.1.6 Reckitt Benckiser Group plc. 10.1.6.1 Company Overview 10.1.6.2 Financial Performance 10.1.6.3 Product Benchmarking 10.1.6.4 Strategic Initiatives 10.1.7 Sanofi 10.1.7.1 Company Overview 10.1.7.2 Product Benchmarking 10.1.7.3 Strategic Initiatives 10.1.8 Sun Pharmaceuticals Ltd. 10.1.8.1 Company Overview 10.1.8.2 Financial Performance 10.1.8.3 Product Benchmarking 10.1.8.4 Strategic Initiatives 10.1.9 Takeda Pharmaceutical Company Limited 10.1.9.1 Company Overview 10.1.9.2 Product Benchmarking 10.1.9.3 Strategic Initiatives 10.1.10 Procter & Gamble 10.1.10.1 Company Overview 10.1.10.2 Product Benchmarking 10.1.10.3 Strategic Initiatives
Follow Us:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: